APA (7th ed.) Citation

Ribaldone, D. G., Saracco, G., Astegiano, M., & Pellicano, R. (2018). Letter: Biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti- TNF therapy? Alimentary Pharmacology & Therapeutics, 47(1), 146. https://doi.org/10.1111/apt.14321

Chicago Style (17th ed.) Citation

Ribaldone, D. G., G. Saracco, M. Astegiano, and R. Pellicano. "Letter: Biologics Treatment in Crohn's Disease and Risk of Bowel Resection-what About the Patients Who Stop Anti- TNF Therapy?" Alimentary Pharmacology & Therapeutics 47, no. 1 (2018): 146. https://doi.org/10.1111/apt.14321.

MLA (9th ed.) Citation

Ribaldone, D. G., et al. "Letter: Biologics Treatment in Crohn's Disease and Risk of Bowel Resection-what About the Patients Who Stop Anti- TNF Therapy?" Alimentary Pharmacology & Therapeutics, vol. 47, no. 1, 2018, p. 146, https://doi.org/10.1111/apt.14321.